I see a lot of people here focusing on the share price with a view to taking profits if there is a favourable announcement. 50 cents might sound like a round number, but there is no good reason why you would get off the ANP train at that station. It might be smarter to look at the market cap. Even after its recent run, ANPs market cap is small compared to similar biotechs IMO and has plenty of room for growth to reach fair value.
Where others have failed will Atl1102 succeed ?, page-1005
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.8¢ |
Change
-0.004(4.35%) |
Mkt cap ! $79.33M | |||
| Open | High | Low | Value | Volume |
| 9.1¢ | 9.2¢ | 8.7¢ | $87.86K | 983.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 61583 | 8.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.8¢ | 16883 | 1 |
View Market Depth
| Last trade - 15.58pm 17/06/2024 (20 minute delay) ? |
|
|||||
|
Last
8.8¢ |
Change
-0.004 ( 2.76 %) |
||||
| Open | High | Low | Volume | ||
| 9.1¢ | 9.1¢ | 8.7¢ | 237651 | ||
| Last updated 15.58pm 17/06/2024 ? | |||||
| PER (ASX) Chart |
